Meeting Live in 2022, Safely
The Annual Meeting will be live, for the first time in two years, in Tucson Arizona March 13-15. The Program Committee for the 46th Annual Meeting has been hard at work preparing a top-notch scientific program, while the EC and ASPO staff have been working to ensure that we will be able to meet safely in 2022.
ASPO is committed to providing a safe and healthy scientific meeting and has developed the following guidelines.
Responsibility of Attendees
We kindly ask that attendees stay home under the following conditions:
- You have not been fully vaccinated (2 Moderna or Pfizer shots, 1 Johnson & Johnson shot, boosters if you are eligible). Accommodations will be made for individuals who are unable to be vaccinated for medical or religious reasons. Proof of vaccination will be required before arrival. Here are the CDC guidelines on boosters.
- You are at high risk of contracting COVID-19
- You have been exposed to COVID-19 in the 14 days prior to arriving in Tucson, even if you are not showing symptoms
- You have had symptoms of COVID-19 in the last 14 days
- You are unable or unwilling to follow the meeting guidelines outlined below
At the Meeting
- Attendees should assess their health prior to leaving their room each morning, if you have any symptoms of COVID-19, please contact conference staff who can provide you with a rapid test.
- Attendees will be required to wear a face mask in all public spaces.
- Attendees will be provided ribbons for their conference badges indicating their preference for interacting with fellow attendees (elbow bumps welcome, I’m being cautious, 6 feet of distance)
- Hand sanitizing stations will be set up outside each event and next to each podium. Attendees will be required to use them as they enter and exit.
- Meals, snacks, and beverage stations will be contactless.
- Social functions will be held outdoors whenever possible.
- The hotel will implement increased cleanings and sanitizing of surfaces and door handles.
These guidelines are subject to change. Last updated: February 11, 2022
Lucile was the first African-American woman to receive a PhD in epidemiology in the United States, and in 1995 when she directed the Howard University Cancer Center she was the only African-American woman to lead any cancer institute. She is currently the Associate Director of Minority Health & Health Disparities Research, Senior Associate Dean for Community Outreach and Engagement, and Professor of Oncology at Lombardi Comprehensive Cancer Center at Georgetown University Medical Center. Dr. Adams-Campbell has dedicated her career to studying cancer disparities experienced by African-Americans. Her research uses clinical trials, cancer epidemiology and etiology along with lifestyle interventions to elucidate the cancer risk in African-Americans and has led to over 200 peer-reviewed publications and international recognition as an expert in minority health and health disparities research.
Bo has unequivocally demonstrated an unyielding commitment to tobacco control efforts by enabling innovative research and spearheading public education, policy and advocacy initiatives. Her strong leadership, like Dr. Cullen’s, exemplifies a commitment to fostering collaboration among scientists, health care professionals, and public health advocates involved in the struggle against tobacco and tobacco-related diseases.
Health inequities are not new. However, the ongoing COVID-19 pandemic and recent death of George Floyd among many other people of color has brought the issues of systemic structural racism and discrimination and health inequity into the forefront of American consciousness. Communities of color, and people who are low income, rural, LGBTQ+, immigrants, and Indigenous, among others, face disproportionate and inequitable cancer burden. While advances in prevention and control research have led to improvements in cancer incidence and better survival from cancer overall, U.S. cancer inequities persist, and for some populations, gaps have widened over time.
